ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy

BACKGROUND: Possible targeted therapies for metastatic triple negative breast cancer (TNBC) include cytotoxic chemotherapy that causes interstrand breaks (platinum-based drugs). The excision repair cross-complementation 1 (ERCC1) enzyme plays an essential role in the nucleotide excision repair pathw...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Asian Pac J Cancer Prev
Autors principals: Baiomy, Mohamed Ali EL, El Kashef, Wagdi F
Format: Artigo
Idioma:Inglês
Publicat: West Asia Organization for Cancer Prevention 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5454751/
https://ncbi.nlm.nih.gov/pubmed/28345838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.2.507
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars